Article Information
History
- June 25, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Spyros Chalkias1,*,
- Charles Harper2,
- Keith Vrbicky2,
- Stephen R. Walsh3,
- Brandon Essink4,
- Adam Brosz5,
- Nichole McGhee1,
- Joanne E. Tomassini1,
- Xing Chen1,
- Ying Chang1,
- Andrea Sutherland1,
- David C. Montefiori6,
- Bethany Girard1,
- Darin K. Edwards1,
- Jing Feng1,
- Honghong Zhou1,
- Lindsey R. Baden3,
- Jacqueline M. Miller1 and
- Rituparna Das1
- 1Moderna, Inc., Cambridge, Massachusetts, USA
- 2Meridian Clinical Research, Norfolk, Nebraska, USA
- 3Brigham and Women’s Hospital, Boston, Massachusetts, USA
- 4Meridian Clinical Research, Omaha, Nebraska, USA
- 5Meridian Clinical Research, Grand Island, Nebraska, USA
- 6Department of Surgery and Duke Human Vaccine Institute, Durham, North Carolina, USA
- ↵*Corresponding Author:
Spyros Chalkias, MD, Moderna, Inc., Cambridge, MA, USA 02141-2025, Email: spyros.chalkias{at}modernatx.com, Cell phone: 617-335-0744